ArticleGels (Basel, Switzerland)2026
GelMA Versus Agarose Hydrogels in Pancreatic Cancer 3D Spheroid Modeling: Effects on Morphology, HIF-1α Expression, and Gemcitabine Response.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given its highly aggressive nature and poor clinical outcome, pancreatic ductal adenocarcinoma (PDAC) requires physiologically relevant in vitro models that more accurately reflect tumor biology and drug response. In this study, adhesive and non-adhesive hydrogel microenvironments were comparatively evaluated for pancreatic cancer spheroid modeling using PANC-1 and MIA PaCa-2 cells. Gelatin methacryloyl (GelMA) hydrogels were synthesized, photocrosslinked, and optimized in terms of stability, swelling, degradation, and cytocompatibility, while 3% agarose was used as a non-adhesive counterpart. Although the optimized GelMA formulation showed adequate structural stability and no cytotoxicity, it did not support spheroid formation. In contrast, agarose enabled the formation of compact, viable, and proliferative spheroids in both cell lines. Agarose-derived spheroids exhibited time-dependent growth, positive Ki-67 staining, and increased HIF-1α expression under 3D conditions, indicating the establishment of hypoxia-associated tumor-like microenvironments. Gemcitabine treatment induced a time-dependent reduction in spheroid viability, while viable cell populations persisted throughout exposure, reflecting the heterogeneous therapeutic response typical of 3D tumor models. Overall, these findings provide a comparative, microenvironment-based assessment of pancreatic cancer spheroid modeling, indicating that hydrogel-dependent differences in adhesivity and structural dynamics are important determinants of spheroid assembly, hypoxia-associated molecular adaptation, and chemotherapeutic response. Overall, these findings provide a comparative, microenvironment-based assessment of pancreatic cancer spheroid modeling, indicating that hydrogel-dependent differences in adhesivity and structural dynamics are important determinants of spheroid assembly, hypoxia-associated molecular adaptation, and chemotherapeutic response. Overall, these findings provide a comparative, microenvironment-based assessment of pancreatic cancer spheroid modeling, indicating that hydrogel-dependent differences in adhesivity and structural dynamics are important determinants of spheroid assembly, hypoxia-associated molecular adaptation, and chemotherapeutic response.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.